insights_auto
Why is CUV up 2,29%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7,59
arrow_upward
+2,29%(+0,17) 1D
16 Nov., 16:10:15 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7,43
High
A$7,65
Low
A$7,38
Mkt. cap
383,20 m
Avg. vol.
157,65 k
Volume
90,51 k
Dividend
0,66%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,36
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 m
No. of employees
16
Open
A$7,43
High
A$7,65
Low
A$7,38
Mkt. cap
383,20 m
Avg. vol.
157,65 k
Volume
90,51 k
Dividend
0,66%
Quarterly dividend
A$0,01
Ex-dividend date
03 Sep. 2026
P/E ratio
11,36
52-wk high
A$13,48
52-wk low
A$6,62
EPS
A$0,67
Shares outstanding
50,49 m
No. of employees
16
News stories
From web sources and news partners
MarketWatch
·
1 uur gelede
Stock Market Today: Dow, S&P 500 and Nasdaq are set to fall as investors await Nvidia results and Anthropic's IPO this week: live updates
Investing.com
·
58 minute gelede
Morgan Stanley raises S&P 500 target on earnings growth, lower oil and AI adoption
The Motley Fool
·
2 uur gelede
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
Billionaires.Africa
·
13 minute gelede
American billionaire Elon Musk's SpaceX eyes S&P 500 entry through Tesla merger
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
Industry-
Websiteclinuvel.com